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MitophagyCells precisely regulate mitochondrial movement in order to balance energy needs and avoid cell death.
Neurons are particularly susceptible to disturbance of mitochondrial motility and distribution due to their
highly extended structures and specialized function. Regulation of mitochondrial motility plays a vital role
in neuronal health and death. Here we review the current understanding of regulatory mechanisms that
govern neuronal mitochondrial transport and probe their implication in health and disease. This article is
part of a Special Issue entitled: Mitochondrial dynamics and physiology.
Published by Elsevier B.V.1. Introduction
Mitochondria, best known as the powerhouses of cells, are cyto-
plasmic organelles of an endosymbiotic origin. Mitochondria have
their own distinct haploid DNA which encodes essential enzymes
for oxidative phosphorylation and mitochondrial tRNAs, but are as-
sembled from proteins mostly encoded by nuclear DNA. Although
ATP conversion by aerobic respiration is their major job, mitochon-
dria also provide a reservoir for cytosolic calcium ions, and synthesize
certain heme compounds [1] and steroids [2]. The uniqueness of these
features places mitochondria in a signiﬁcant position for regulating
cellular proliferation and death [3].
Mitochondria move and undergo ﬁssion and fusion in almost all
eukaryotic cells. This dynamic nature holds a particular urgency for
neurons because of the problems that can arise during the long-
range transport that is necessitated by the remarkable length and
complexity of axons and the variable and specialized energetic de-
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.V.neurons are especially susceptible to disruption of the proper alloca-
tion of mitochondria [4]; both the presynapse and postsynapse have
particularly high demands for energy and Ca++ buffering. To sustain
the periphery, newly assembled mitochondria from the cell body
must be transported into neurites, and peripheral mitochondria
whose proteins and DNA accumulate defects must be either repaired
by fusion with fresh mitochondria or cleared from the cell [5]. Be-
cause the cell body is enriched with ribosomes, lysosomes, and
other organelles, damaged mitochondria might be transported back
to the cell body to be replenished or degraded. Therefore, in order
to keep energy homeostasis and maintain essential activities, neurons
need not only to precisely set up an adequate distribution of mito-
chondria, but also to efﬁciently sustain them in the periphery and
clear them away when necessary. An exquisite regulation of mito-
chondrial movement is required to achieve these goals.
Misregulated mitochondrial motility in neurites is predicted to
cause neuronal dysfunction and degeneration. Abnormalities in mito-
chondrial motility and distribution are implicated in a wide range ofl Sclerosis; CCCP, Carbonyl cyanide m-chlorophenyl hydrazine; CMT, Charcot–Marie–
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Marie–Tooth (CMT) [6], Amyotrophic Lateral Sclerosis (ALS) [7],
Alzheimer's [8–10], Huntington's [11], Parkinson's [12], and schizo-
phrenia [13]. However in these diseases mitochondrial function of ox-
idative phosphorylation and generation of ATP may be disrupted by
primary neurotoxic factors and cellular stresses. Malfunctioning mi-
tochondria can affect mitochondrial motility [12], and cause neuronal
cell death by generating reactive oxygen species and triggering apo-
ptosis [14]. Therefore the part the misregulation of mitochondrial
motility plays in disease progression merits further investigation. It
is certain, however, that both misregulated mitochondrial motility
and function can expedite the cell death process in neurons already
vulnerable or stressed [15,16]. Here we review the current under-
standing of the cellular signals that regulate neuronal mitochondrial
motility, as well as their signiﬁcance and implication in neuronal
health and disease.
2. Mitochondrial transport machinery
In neurites approximately 30–40% of totalmitochondria are engaged
in saltatorymovement at any given time [17–20]. The densities ofmito-
chondria at different synapses therefore change constantly. This reﬂects
an acute need formitochondria to buffer Ca++ inﬂux and distribute ATP
among the microdomains of a neuron [21]. A mitochondrion can either
move continually over a long distance at a relatively constant speed, or
pause sporadically and start again with a different speed or direction.
Fission-and-fusion events can also occur in moving mitochondria,
though the relationship between movement and ﬁssion-and-fusion is
unclear. Study in non-neuronal cells suggests that fusion events happen
more frequently while mitochondria are moving [22]. The majority of
mitochondrial movement is microtubule-based [17,21,23]. In an axon
microtubules are uniformly arrayed, with all (+)-ends pointing to the
axonal terminal and the (−)-ends to the cell body, whereas in a den-
drite their polarities are typically more mixed [24]. Anterograde move-
ment toward the (+)-ends of microtubules is mediated by kinesin
motors, and retrograde toward (−)-ends by dynein motors. These
motor proteins are generally shared with other cellular cargoes moving
along microtubules. Mitochondria are anchored to motor proteins by
idiosyncratic adaptor proteins; in this way their motility is precisely
and speciﬁcally regulated by cellular signals (Table 1).
Mitochondria are also transported along actin ﬁlaments, a process
that happens more frequently in dendritic spines, growth cones, and
synaptic boutons where the actin cytoskeleton is enriched. This
actin-based movement is relatively short-ranged, likely mediated by
myosin motors, and important for local and acute translocation and
docking of mitochondria in response to action potentials, Ca++ in-
ﬂux, or neurotrophic stimulation (Table 1). Actin-based transport
can also coordinate, supplement, or even oppose microtubule-based
transport [25].
2.1. Anterograde microtubule motors
In mammals, at least 14 families and 45 genes of kinesins have been
identiﬁed to date, of which the Kinesin-1 family has been shown to beTable 1
Summary of current understanding of transport machineries for mitochondria. See also
Section 2.
Motor Adaptor/associated proteins Cytoskeleton Illustration
KHC Milton, Miro Microtubules Fig. 1A
Syntabulin/FEZ1/RANBP2/more Microtubules Fig. 1B
KIF1Bα KBP, more Microtubules Fig. 1C
KLP6 KBP, more Microtubules Fig. 1C
Dynein Dynactin, more Microtubules Fig. 1D
Myo19, more Unknown Actin Fig. 1Ecritical for mitochondrial transport [26–29]. Kinesin-1 is also known as
the conventional kinesin heavy chain (KHC), or KIF5. Each KIF5 gene con-
tains an N-terminal motor domain that binds tomicrotubules and hydro-
lyzes ATP, and a C-terminal domain that can interact with kinesin light
chain (KLC) or cargo adaptors. Three KIF5 genes exist in mammals: two
are neuronal-speciﬁc (KIF5A and KIF5C), while one is ubiquitously
expressed (KIF5B). Mutations inmice KIF5B lead to perinuclear clustering
of mitochondria, which indicates a disruption of kinesin-mediated anter-
ograde transport of mitochondria [29]. In Drosophila, when the only
orthologue of KIF5 ismutated axonalmitochondrial transport is impaired
[30]. In both neuronal and non-neuronal cells KIF5 is recruited exclu-
sively tomitochondria from cytosol by overexpression ofmitochondrial
adaptor proteins [19,31], and overexpression of the motor domain of
KIF5 in hippocampal neurons alters the regulation ofmitochondrialmo-
tility by interferingwith the integrity of themitochondrial motor/adap-
tor complex [19].
In addition, two members of the Kinesin-3 family are associated
with mitochondria; KIF1Bα and Kinesin-Like Protein 6 (KLP6).
KIF1Bα is expressed ubiquitously and is particularly abundant in dif-
ferentiated neuronal cells. The motor has been shown to colocalize
with mitochondria and facilitate their (+)-end directed transport in
vitro [32]. Knockdown of KLP6 disrupts anterograde axonal transport
of mitochondria in neuronal cells and expression of a dominant neg-
ative KLP6 affects mitochondrial morphology in HeLa cells [33].
2.2. Anterograde microtubule adaptors
2.2.1. The KHC/milton/Miro complex
The KHC/milton/Miro complex is the best understood motor/
adaptor complex for the regulation of mitochondrial transport. The
current model suggests that Miro functions as a receptor with a trans-
membrane (TM) domain integrated into the outer mitochondrial
membrane, and Miro binds to milton, which in turn binds to KHC.
This complex allows mitochondria to associate with microtubules
and plays key roles in regulating mitochondrial motility (Fig. 1A).
Milton came from a genetic screen in Drosophila for identiﬁcation of
mutants that disrupt synaptic transmission in photoreceptors, and
was named after the 17th-century blind English poet John Milton
[34]. Mitochondria are absent from axons deﬁcient in milton but are
present and functional in cell bodies. Milton is localized to mitochon-
dria, and has a predicted coiled-coil domain interacting directly with
KHC. Overexpression of milton in cultured mammalian cells recruits
KHC to mitochondria [19,31,34]. In addition, the interaction between
milton and KHC is KLC independent: KLC is not recruited to mito-
chondria by milton nor is it present in the KHC–milton complex
[31]. Knockout of KLC in ﬂies does not impair mitochondrial transport,
suggesting that KLC is dispensable for their movement [31]. Milton
has two homologues in mammals, TRAK1 (also known as milton-1,
OIP106) and TRAK2 (milton-2, GRIF1), which are about 30% identical
to Drosophila milton in their amino acid sequence. Both homologues
also interact with KHC [35,36]. Knockdown of TRAK1 but not TRAK2
in cultured neurons impairs axonal mitochondrial movement, which
can be rescued by expression of either TRAK1 or TRAK2 [37]. These
ﬁndings reveal an important and conservative role of TRAK as a KHC
adaptor in regulating mitochondrial motility. Differences do exist be-
tween Drosophila and mammalian milton homologues: whereas Dro-
sophila mutants appear to be selectively defective in mitochondrial
transport, there is evidence that the mammalian homologues may
be associated with additional organelles [35,38–40].
KHC and milton need a third protein, Miro, to attach them to mito-
chondria. There is one Miro gene in Drosophila, and two (Miro1 and
Miro2) in mammals. Each contains two GTPase motifs, a pair of EF-
hands involved in Ca++ binding, and a C-terminal TM domain that in-
corporates into the outer mitochondrial membrane [41,42]. Similarly to
milton mutants, neurons deﬁcient in Drosophila Miro lack axonal mito-
chondria [43]. Miro binds to milton directly, and Miro, milton and KHC
Fig. 1. Schematic representations of mitochondrial transport machineries. Protein complexes that move mitochondria along microtubules including A) KHC/milton/Miro, B) KHC/
syntabulin (FEZ1, RANBP2), C) Kinesin-3/KBP, D) dynein/dynactin, and along actin, E) Myo19, and docking machinery along microtubules and F) syntaphilin. “Protein X” indicates
additional unidentiﬁed proteins on the outer mitochondrial membrane.
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[19,31]. This complex plays a key role in conveying cellular signals to
control mitochondrial movement, as will be discussed later.
2.2.2. Other KHC complexes
Besides Miro and milton, several other proteins have been found
to connect KHC to mitochondria (Fig. 1B). Syntabulin can directly
attach KHC to the outer mitochondrial membrane, and anterograde
axonal transport of mitochondria is disrupted when syntabulin is
knocked down by RNAi in cultured hippocampal neurons [44]. Fascic-
ulation and elongation protein-zeta 1 (FEZ1) can also bind to KHC and
anterograde axonal transport of mitochondria is impaired when FEZ1
is disrupted in neurons [45,46]. RAN-binding protein 2 (RANBP2) has
been shown to interact with KIF5B and KIF5C (but not KIF5A), andinterrupting its function or its interaction with KHC affects mitochon-
drial distribution in both neuronal and non-neuronal cells [47]. It is
likely that additional unidentiﬁed proteins are needed to attach
these adaptor proteins and KHC to the outer mitochondrial mem-
brane, and their speciﬁc roles in regulating neuronal mitochondrial
motility need further investigation.
2.2.3. The Kinesin-3/KBP complex
Both KIF1Bα and KLP6 from the Kinesin-3 family interact with
KIF1-Binding Protein (KBP). Together with other scaffolding proteins
they may form a motor/adaptor complex to regulate mitochondrial
motility [33] (Fig. 1C). KBP is localized to mitochondria and down-
regulation of KBP protein levels leads to perinuclear aggregation of
mitochondria [48]. KBP is also essential for normal axonal outgrowth
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opment [49].
2.3. Retrograde microtubule motors and adaptors
The mechanisms and adaptor proteins for retrograde movement
of mitochondria are less clear, although cytoplasmic dynein has
been shown to be the motor [30]. In contrast to numerous kinesins,
only one dynein exists. However, it is composed of multiple compo-
nents and forms complicated structures that may give dynein func-
tional diversity (Fig. 1D). Dynein includes two heavy chains that
function as motors and interact with microtubules, several intermedi-
ate chains, light intermediate chains and light chains that regulate its
functions and attachments to cargoes. An auxiliary complex com-
posed of 11 subunits, dynactin, binds to dynein and microtubules
directly via its largest subunit, p150. Dynactin may facilitate the
processivity of the dyneinmotor or its cargo binding [50]. In Drosophila,
subunits of both dynein and dynactin have been found to be associated
with mitochondria, and mutations in dynein heavy chain and p150 im-
pair retrograde axonal transport of mitochondria [30]. It is unknown
how dynein accomplishes speciﬁc cargo recognition, or how dynein
manages to attach to the outer mitochondrial membrane. The relation-
ship between dynein and kinesin seems to be complicated; mutations
of KHC in ﬂies disrupt retrograde mitochondrial movement in addition
to their disruption of anterograde movement [30], and dynactin has
been reported to coordinate both anterograde and retrograde move-
ment [51]. Are kinesin and dynein present on the samemitochondrion?
Do they coordinate with or oppose each other? How does each mito-
chondrion decide which direction to go? Do kinesin and dynein share
the same mitochondrial adaptors? One indication comes from studies
of Miro, the kinesin-associated mitochondrial receptor. Mutating the
functional domains or key residues of Miro tomake it insensitive to cel-
lular signals that regulatemitochondrial motility (details in Section 3.1)
inhibits the regulation in both anterograde and retrograde directions
[12,19]; Drosophila Miro seems to promote mitochondrial motility in
both directions [52]. These data suggest that Miro is also involved in
the regulation of dynein-mediated mitochondrial transport, either di-
rectly by acting on dynein or indirectly through kinesin.
2.4. Actin motors and adaptors
Although mitochondria are able to travel along actin [53], little is
known of actin motors or their mitochondrial adaptors. A recent study
identiﬁed Myo19 as a new myosin motor for mitochondria [54].
Myo19 is exclusively localized tomitochondria and regulatesmitochon-
drial morphology and actin-basedmitochondrial transport. It is still un-
known if Myo19 binds to the mitochondrial membrane directly or via
its binding partners (Fig. 1E). Since Myo19 is ubiquitously expressed,
it is possible that Myo19 mediates actin-based mitochondrial move-
ment in neurites, spines and boutons. Other candidates in neurons in-
clude Myosin II, III, V and VI [25,55,56], although evidence of a direct
associationwithmitochondria is still lacking. Knowledge of motor associ-
ated proteins that regulate actin-based mitochondrial movement is even
scarcer. TheWASP family verprolin homologous protein 1 (WAVE1) that
regulates actin polymerization has been recently shown to control
depolarization-induced mitochondrial movement into spines and
ﬁlipodia and regulate spine morphogenesis [57].
2.5. Molecular brakes
In neurons, the majority of mitochondria are immobile. At many sub-
cellular regions that need a constant energy supply, such as places of pro-
tein synthesis or sites occupiedwith ion pumps, static mitochondria are
always located nearby like gas stations. In addition, on many occasions
mobile mitochondria can temporarily stop and start moving again. This
suggests that mitochondria not only need motors to move themselves,but also additional regulation to dock and stabilize them at various sub-
cellular locations. It is possible that once mitochondria are dissociated
frommicrotubules or motors, they are able to remain static in the cyto-
sol. It has also been suggested that actin-based regulation docks mito-
chondria away from microtubules to presynaptic boutons, dendritic
spines, or growth cones where actin is enriched and mitochondria are
more needed [58]. Recently, a microtubule-interacting protein, syn-
taphilin, has been identiﬁed as a mitochondrial anchor (Fig. 1F): mo-
bile mitochondria stop once they bind to syntaphilin, while still
being attached to motors and microtubules [59]. A dynein light
chain, LC8, has been shown to be involved in this immobilization
by stabilizing syntaphilin–microtubule interactions [60]. Additional
mechanisms are yet to be identiﬁed to explain the docking of mi-
tochondria under various circumstances.
3. Regulation of mitochondrial movement
3.1. Regulations by the KHC/milton/Miro complex
This primary motor/adaptor complex mediating anterograde
axonal transport of mitochondria is employed by diverse cellular
signals to allow distinct cellular demands to inﬂuence mitochondrial
transport.
3.1.1. Splicing variants of milton
At least four different proteins (named milton A–D) are translated
from Drosophila milton due to alternative splicing, and they only differ
at their N-termini. All milton variants contain the coiled-coil KHC-
interacting region and are expected to bind to and recruit KHC to
mitochondria [31]. Yet one of the variants, milton-C, fails to do so
[31]. It has not been documented how the variants of milton are
expressed in neurons. These raise the interesting possibility that
different variants of milton may have disparate roles, can respond
to variable physiological stimuli, or may be expressed distinctively
(Fig. 2A). In Drosophila early developing oocytes acquire and multiply
mitochondria and other organelles via directional microtubule-based
transport in an accumulation known as the Balbiani body. A study
showed that milton is essential for mitochondrial transport to form
the Balbiani body, and suggests that milton-A facilitates (+)-end
movement via kinesin, while milton-B facilitates (−)-end movement
via dynein [61]. In addition, since KHC always forms a dimer, milton is
potentially a dimer as well. Four forms of milton monomer can make
ten different combinations of the milton dimer if they are expressed
in the same cell, and a combinatorial mechanism can also serve as a
means to deliver different commands to mitochondrial transport
machineries. Mammalianmilton-2 (TRAK2) has three splicing variants
and the differences are unclear [62]. Additional studies are needed to
determine the roles and expression patterns of the splicing variants of
milton. Much less is known about the variants of Miro, although they
do exist (Ensembl). Likemilton, alternative splicing ofMiromay play a
role to regulate the motor/adaptor complex.
3.1.2. OGT and O-GlcNAcylation
In addition to KHC and Miro, milton binds to another protein, OGT
(O-linkedN-acetylglucosamine transferase) in an interaction conserved
between ﬂies andmammals [31,63] (Fig. 2B). OGT and the KHC/milton/
Miro complex can form a quaternary complex [64]. OGT is an enzyme
that catalyzes a posttranslational modiﬁcation called O-GlcNAcylation:
it is able to attach small sugar UDP-GlcNAc (Uridine diphosphate
N-acetylglucosamine) to naked proteins at Serine and Threonine resi-
dues by covalent ligation, and another enzyme, O-GlcNAcase, reversibly
removes it [65]. In contrast to phosphorylation which is fulﬁlled by the
400 Serine/Threonine kinases encoded by the human genome [66],
O-GlcNAcylation is carried out by a single and highly conserved OGT
gene [67]. O-GlcNAcylation regulates various cellular events including
cytoskeletal dynamics, signal transduction, organelle trafﬁcking, and
Fig. 2. Schematic representations of cellular signals that may regulate mitochondrial transport. A) Splicing variants of milton; B) O-GlcNAcylation and OGT; C) Ca++; D) mitochondrial
damage and PINK1/Parkin; E) GTP/GDP; F) hypoxia and HUMMR; G) various other signals.
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localized to cytosol, nucleus, and cytoplasmic organelles including mi-
tochondria. Both mammalian and Drosophila milton have been shown
to be substrates of OGT and can be modiﬁed by UDP-GlcNAc [31,63].
Therefore O-GlcNAcylation likely controls certain cellular events such
as mitochondrial movement through milton by modifying it.
What upstream cellular signal does O-GlcNAcylation represent to
regulate milton and mitochondrial movement? The catalytic activity of
OGT may be activated or inactivated by upstream proteins or signals.
The availability of small sugar UDP-GlcNAc may drive the equilibrium
of the reaction as well, to control the amount of O-GlcNAcylation onmil-
ton or the amount of milton O-GlcNAcylated. Glucose is the source of
UDP-GlcNAc, and 2–5% of total glucose is converted to UDP-GlcNAc via
the hexamine biosynthetic pathway (HBP). If glucose inﬂuences
O-GlcNAcylation of milton by UDP-GlcNAc and OGT, mitochondrial
movement may be altered by subcellular metabolic conditions.
Neurons depend on glucose and oxidative phosphorylation almost
exclusively for energy supply, whichmakes them unique inmaintaining
their metabolic and energetic homeostasis [68]. Regulation of mitochon-
drial motility by OGT and the KHC/milton/Miro complex along the ex-
tensions of axons may be needed to support a healthy metabolic state
of a neuron. Further investigation of how OGT and O-GlcNAcylation reg-
ulate mitochondrial motility and their relationships to glucose and theKHC/milton/Miro complex, in both neuronal and non-neuronal cells,
may unravel the remaining puzzles.
3.1.3. Cytosolic Ca++
Another important cellular signal that regulates mitochondrial
motility is cytosolic Ca++. Resting levels of cytosolic Ca++ permit
mitochondrial movement, whereas elevation of the concentration
by calcium ionophores completely inhibits mitochondrial motility in
both neuronal and non-neuronal cells [19,69,70]. Why is Ca++ used
to stop mitochondria? It has been shown that concentrations of cyto-
solic Ca++ are not uniform across subcellular regions and areas of
lower ATP concentrations may have higher Ca++ concentrations
[71]. In neurons, this heterogeneity is more evident: in synapses
and dendritic spines, the high energy demands necessary to maintain
action potential ﬁring and ion gradients across membranes are
accompanied with high Ca++ inﬂux. Therefore, mitochondria are
arrested at places where Ca++ concentration is higher and ATP con-
centration is lower, probably by buffering extra Ca++ and providing
more ATP to regulate both Ca++ and energy homeostasis. Ca++
halts mitochondrial movement by binding to the EF-hands of Miro
in the mitochondrial motor/adaptor complex, therefore inducing a
direct interaction between Miro and the motor domain of KHC, and
interfering with KHC motor/microtubule binding. Consequently, the
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from microtubules and mitochondria stop moving (Fig. 2C). This reg-
ulation is transient and reversible, likely representing a temporary
and local need for mitochondria [19]. An alternative model suggests
that Ca++ disrupts the integrity of the KHC/milton/Miro complex
and dissociates mitochondria from KHC motors and microtubules
[70], though this model has not been conﬁrmed by other studies
[19,64,72]. When the key glutamate residues within the EF-hands of
Miro aremutated to lysines to prevent Ca++-binding, Ca++-dependent
mitochondrial arrest is abolished in both anterograde and retrograde
directions [19,69,70]. Since KHC regulates the transport of other
cargoes, this mechanism via the mitochondrial adaptor Miro explains
the mitochondrial speciﬁcity for Ca++ regulation; Ca++ stops mito-
chondria, not other cargoes transported along microtubules. Physio-
logically, the EF-hands of Miro mediate the glutamate-dependent
mitochondrial arrest, which protects neurons during excitotoxic stress
[19].
3.1.4. The PINK1/Parkin cascade
Another signaling pathway that regulatesmitochondrialmotility via
this common KHC/milton/Miro complex is the PINK1/Parkin cascade.
PINK1 (The PTEN Induced Kinase 1) and Parkin are two Parkinson's
disease proteins. Mutations in their encoding genes cause autosomal
recessive early onset Parkinson's disease in humans [73,74]. Parkinson's
disease is the second most common neurodegenerative disease with a
selective loss of midbrain dopaminergic neurons. PINK1 encodes a
Serine/Threonine kinase with an N-terminal mitochondrial targeting
sequence (MTS), and can be localized to either the outer or inner mito-
chondrial membrane depending onmitochondrial membrane potential
[75]. Parkin encodes an E3 ubiquitin ligase and is likely involved in the
ubiquitin-proteasomal-degradation pathway. With PINK1 functioning
upstream of Parkin in a common pathway, both PINK1 and Parkin
regulate mitochondrial morphology and function [76–80], and are in-
volved in a mitochondrial quality control process known as mitophagy
[81–85], which clears damaged mitochondria via autophagic engulf-
ment. The PINK1/Parkin pathway can be activated by mitochondrial
depolarization and damage [10,81–85].
Both PINK1 and Parkin can physically interact with the KHC/milton/
Miro complex and their interaction with Miro is enhanced by depolari-
zation of mitochondrial membrane potential [12,86]. This is consistent
with ﬁndings that PINK1 is stabilized on the outer mitochondrial mem-
brane and Parkin is recruited tomitochondria from cytosol whenmem-
brane potential is compromised [75]. The direct binding of the
mitochondrial transport complex to PINK1 ledWang et al. to investigate
the roles of the PINK1/Parkin pathway in the regulation ofmitochondri-
al transport. The results [12] showed that excessive amount of PINK1 or
Parkin, or depolarization of mitochondrial membrane potential, arrests
mitochondrial transport in both anterograde and retrograde directions
through proteasomal degradation of Miro in rodent and Drosophila
axons. The removal of Miro from mitochondria releases KHC from the
mitochondrial surface. PINK1 has been demonstrated to phosphorylate
Miro and this phosphorylation triggers its Parkin-dependent degrada-
tion (Fig. 2D). A recent study conﬁrmed that Miro is the target of the
PINK1/Parkin cascade and can be ubiquitinated by Parkin, and suggests
that the degradation of Miro is a key step in generating PINK1 mutant
phenotypes in ﬂies and facilitating mitophagy in HeLa cells [87]. It is
likely that arresting mitochondrial motility in this manner is an early
step in the quarantining of damaged mitochondria for subsequent
mitophagy. In individuals lacking either functional PINK1 or Parkin, a
failure to isolate, stop and remove the damagedmitochondriawill likely
contribute to neuronal cell death. PINK1 and Parkin represent an evolu-
tionarily conserved pathway to regulate mitochondrial motility, by
acting on a common target Miro. Unlike Ca++, this regulation initiates
an irreversible and permanent process to clear damaged mitochondria.
More questions remain to understand this cascade in mitophagy. The
absence or reduction of PINK1 in ﬂies does not affect the ability of Parkinoverexpression to impair mitochondrial motility [12] and morphology
[76], indicating that PINK1 phosphorylation on its substrates such as
Miro is likely to stimulate Parkin function, but probably not absolutely
necessary. It is less clear if this cascade has crosstalk with other pathways
that are necessitated by mitophagy. For example, massive mitochondrial
depolarization may activate more than one kinase besides PINK1 to en-
hance Parkin activities. Wang et al. have noticed that overexpression of
exogenous PINK1 and Parkin together had a bigger effect on Miro degra-
dation than overexpression of either individually [12]. A recent study has
shown that Parkin does not form a stable complex with PINK1, and re-
cruitment of Parkin alone to mitochondria without activation of PINK1
is not able to ubiquitinate mitochondria and induce mitophagy [88].
These ﬁndings exclude the possibilities that the primary role of PINK1 is
to recruit Parkin to mitochondria and that the mitochondrial presence
of Parkin alone is sufﬁcient to trigger mitophagy. The relationship be-
tween PINK1 and Parkin may be perplexing, and more proteins may be
involved in between. Thismay also explain the discrepancies in the extent
of degradation of exogenous Miro by overexpressed PINK1, Parkin, or
treatment with CCCP, a mitochondrial depolarizer. The ratios of amounts
of overexpressed Miro, PINK1, or Parkin are crucial to determine the re-
sults in different cell lines. WhenMiro synthesis outpaces its degradation
caused by the overexpression of either enzyme, Miro protein remains
[12]. Blocking the major phosphorylation site Serine156 of Miro resisted
degradation best when an appropriate amount of PINK1 or Parkin was
overexpressed individually [12], but inadequately when extra amounts
of PINK1 and Parkin were overexpressed together, with or without
CCCP treatment [87]; additional sites on Miro for PINK1 (such as Threo-
nine298, 299) [12] or for other kinases may be phosphorylated to stimu-
late Parkin function under the latter condition.
It is unclear what the fate of these arrested and damagedmitochon-
dria is in the axons. Since lysosomes are found more abundant in cell
bodies [89], damaged mitochondria may fuse with autophagosomes in
situ and be subsequently transported back to cell bodies for lysosomal
degradation, via retrograde axonal transport of autophagosomes inde-
pendent of the KHC/milton/Miro complex which is speciﬁc to mito-
chondria. However, since lysosomes do exist in the axons [90], it is
possible that local lysosomal fusion could occur. It is also possible that
there is a preference for the cell bodies over the axons as the site of ac-
tivation of this cascade in vivo. Maybe under physiological conditions
when there are no global mitochondrial damages, it is more economical
to activate the PINK1/Parkin cascade in the cell bodies to prevent dam-
aged mitochondria from moving out into the axons.
Studies of this cascade suggest that mitochondrial importation of
PINK1 could happen at the distal part of axons, and support the view of
a constant and localmitochondrial biogenesis. PINK1 is continually impo-
rted into healthymitochondria and subsequently degraded, and it ac-
cumulates on the outer mitochondrial membrane of damaged
mitochondria because its importation is blocked by compromised
membrane potential [75]. How does PINK1 reach mitochondria
in axonal processes to either be imported or be stabilized on the
outer mitochondrial membrane? Is PINK1 protein or mRNA trans-
ported there from the cell bodies along axons? If so, does this
apply to other mitochondrial proteins? Are anterograde axonal
transport of the necessary components and local protein transla-
tion the way by which axonal mitochondria replenish their proteins
and maintain biogenesis within the terminals? Obviously the remote
part of axons is more susceptible to problems that arise during this
long-range transport, and a shortage of PINK1 to the distal mitochondria
due to disrupted transport may contribute to themitochondrial malfunc-
tion and neurodegeneration in neurons with particularly long axons.
3.1.5. Other possible signals through the complex
Mirowas identiﬁed as an atypical RhoGTPase and has two function-
al GTPase domains [41,42]. While many relatives of Miro in the Rho
GTPase subfamily such as RhoA, Rac1, and cdc42 regulate cell morphol-
ogy and motility [41], and other large GTPase proteins localized to
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like protein 1), and OPA1 (optic atrophy 1) control membrane ﬁssion
and fusion, the roles of Miro's GTPase domains are still unclear
(Fig. 2E). Evidence suggests that they might be needed to maintain mi-
tochondrial morphology [42]. It is possible that they control other func-
tions ofMiro or theKHC/milton/Miro complex, such as Ca++-sensing or
OGT-binding, in order to affect mitochondrial motility. Further explora-
tion of how Miro's GTPase domains function is warranted.
Hypoxia up-regulated mitochondrial movement regulator
(HUMMR) also interacts with the KHC/milton/Miro complex and reg-
ulates mitochondrial transport and distribution [91]. HUMMR can be
expressed in neurons and induced by hypoxia-inducible factor 1α
(HIF-1α) (Fig. 2F). Knockdown of HUMMR in hypoxic neurons in-
hibits anterograde axonal transport of mitochondria and promotes
retrograde movement. Hypoxia induces a mild increase in the density
of axonal mitochondria, which is abolished by reduced HUMMR ex-
pression [91]. This may represent a physiological response of mito-
chondrial redistribution to acute stress such as hypoxia, which is an
important factor during ischemic stroke. Induction of HUMMR can
enable more mitochondria to enter the distal part of neurites and syn-
apses, and high Ca2+ inﬂux resulting from glutamate excitotoxicity
can trap mitochondria within the terminals. This response may have
neuronal protective effect during ischemia by gathering extra mito-
chondria to buffer Ca++, but could also aggravate cell death by re-
leasing more reactive oxygen species.
3.2. Regulation by other signals
3.2.1. ADP/ATP
ADP/ATP has been reported to regulate mitochondrial motility in
cultured neurons [92]. This study suggests that in places with higher
energy consumption, such as synapses, intracellular ADP concentra-
tion increases and mitochondria are attracted to sustain ATP supply.
However, how mitochondrial transport machinery senses changes
in concentrations remains elusive. Together with the potential in-
volvement of OGT discussed in Section 3.1.2, these regulatory factors
may permit subcellular metabolic states to allocate mitochondria by
inﬂuencing their motility.
3.2.2. Serotonin (5-HT) and dopamine (DA)
Neurotransmitters including 5-HT and DA have been shown to
alter mitochondrial movement in hippocampal neurons. Mitochon-
drial motility is boosted by activation of the 5-HT receptor via the
AKT-GSK3β (Akt-Glycogen Synthase Kinase 3β) pathway [17];
while mitochondrial motility is inhibited by DA or activation of the
D2 DA receptor via the same AKT–GSK3β pathway [93]. This indi-
cates the involvement of neuromodulators in the control of neu-
ronal growth and energy allocation by regulating mitochondrial
transport. The AKT–GSK3β pathway likely achieves this through
the regulation of kinesin–cargo interactions [94,95].
3.2.3. Nerve growth factor (NGF)
Nerve growth factor (NGF) treatment of cultured neurons causes
accumulation of mitochondria close to where NGF is applied [96],Table 2
Summary of neurological disorders with impaired mitochondrial motility in their disease m
Disease Affected region Proteins bind to mitochon
transport machinery
Parkinson's Dopaminergic neurons in substantia nigra PINK1, Parkin
Alzheimer's Cerebral cortex Unknown
ALS Motor neurons in spinal cord and cortex Unknown
Huntington's Striatum and cortex HTT?
CMT Type 2A Peripheral sensory and motor neurons MFN2?
Schizophrenia Not conﬁrmed Unknownsuggesting that NGF also regulates mitochondrial motility. This effect
appears to be dependent on actin and speciﬁc to mitochondria [58].
The exact mechanism of this phenomenon is still unknown, although
involvement of the PI3 (phosphoinositide-3) kinase pathway has
been suggested [96]. In addition to the signals summarized here,
other unidentiﬁed small molecules and cellular messengers may be
involved in the regulation of mitochondrial movement (Fig. 2G).
4. Misregulation of mitochondrial motility in diseases
Given the particular importance to a neuron of a precise control of
mitochondrial motility and distribution to maintain energy and Ca++
homeostasis, a subtle perturbation could be detrimental to neuronal
health and survival. Misregulated mitochondrial motility and distri-
bution have been found in various neurological disease models and
patients, and emerging evidence suggests their participation in dis-
ease development (Table 2). Because mitochondria play a vital role
in cellular homeostasis, questions remain as to whether abnormality
in mitochondrial motility is a consequence of mitochondrial malfunc-
tion or a key step in neuronal pathogenesis, and whether correction
of mitochondrial motility is worth pursuing as a new strategy for bet-
ter treatments.
4.1. Linking Miro to diseases
4.1.1. Parkinson's disease
Parkinson's disease is a well-characterized mitochondrial dis-
ease, although why dopaminergic neurons in substantia nigra die
ﬁrst remains elusive considering the fact that every disease-
causing gene is ubiquitously expressed. A “mitochondrial damage”
theory has recently come into shape given the emerging evidence
that PINK1 and Parkin, mutations of which cause juvenile heredi-
tary Parkinson's disease, are involved in a mitochondrial-speciﬁc
autophagy process, namely mitophagy, which clears damaged mi-
tochondria [81–85]. The consequence of an impaired mitophagy
process in mutant cells is an accumulation of oxidative stress that
can lead to neurodegeneration. Dopaminergic neurons may be
more susceptible to inefﬁcient mitophagy probably due to their
higher level of cellular stress relative to other cells [97]. However,
the exact roles of these two enzymes in mitophagy are still unclear,
as discussed in Section 3.1.4. How is the PINK1/Parkin pathway ac-
tivated by mitochondrial damage? How do PINK1 and Parkin recog-
nize defective mitochondria in order to initiate mitophagy? How
and where is subsequent autophagosome formation signaled, initi-
ated and completed? Nevertheless, the hypothesis that mutant
PINK1 or Parkin cells may be impaired in their ability to clear dam-
aged mitochondria with resultant injury to neurons is so intriguing
that it makes researchers ponder whether this also accounts for
other types of Parkinson's disease and other neurodegenerative
diseases.
Mitochondrial damage and subsequent activation of the PINK1/
Parkin pathway inhibits mitochondrial motility by directly targeting
Miro in the motor/adaptor complex at a much earlier stage than the
initiation of mitophagy (also see Section 3.1.4) [12]. This suggestsodels. See also Section 4.
drial Potential mechanisms Reference
Target Miro [12,19,86]
Unknown; possibly microtubule abnormality,
protein aggregation, Ca++
[8–10,19,105–108]
Unknown; possibly mitochondrial dysfunction, Ca++ [7,19,72,110,111]
Unknown; possibly protein aggregation, milton, Ca++ [11,19,34,109]
May coordinate with KHC/milton/Miro [6,112]
Unknown [13]
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ﬁrst spot and segregate damaged from healthy mitochondria, to pre-
vent further cell damage from mitochondrial movement and fusion,
and to quarantine them before mitophagy. It could also serve as the
means by which damaged mitochondria are labeled and recognized
by autophagosomes. Failure to do so may interfere with mitochondri-
al clearance and eventually cause neurodegeneration. It is apparent
that the process starting when mitochondria are damaged to ﬁnal
clearance is very complicated, and any error during this process
could cause a delay or halt of mitophagy and an accumulation of ox-
idative stress. An interesting question remains: if we help correct mi-
tochondrial motility, will it restore mitophagy and postpone neuronal
cell death to some extent? Further experiments aimed at correcting
motility abnormality, for example, using mutant forms of Miro, will
be the ﬁrst step in helping answer this question and other questions
designed to improve treatment and change the course of the disease.
The PINK1/Parkin pathway may have additional substrates through
which it regulates mitochondrial physiology and affects mitophagy.
MFN (mitofusin), an outer mitochondrial membrane protein which
controlsmitochondrial fusion, has been shown to be substrate of Parkin,
and is ubiquitinated and degraded upon mitochondrial depolarization
[98–103]. VDAC (voltage-dependent anion channel 1), an outer mem-
brane component of the mitochondrial permeability transition pore
(mPTP) which is involved in apoptosis, is potential target of Parkin as
well [81]. MFN and VDAC have been demonstrated to be important to
facilitate Parkin-dependent mitophagy [81,98–103]. Misregulation of
MFN and VDAC in mutant PINK1 or Parkin cells could interfere with
mitophagy, activate apoptosis, and contribute to neurodegeneration.
The possibility of correcting their malfunctions to hinder neuronal cell
death is worth investigating.4.1.2. Ca++ mediated neurodegeneration
Ca++ is an important signal that can cause neuronal death when
misregulated. Voltage and ligand-gated Ca++ channels populate
both pre- and post-synaptic membranes and change intracellular
Ca++ concentrations instantaneously. Ca++ is taken up by mitochon-
dria via the Ca++ uniporter and released by the Na+/H+–Ca++ ex-
changer, and is able to travel between mitochondria and ER through
their contacts. High Ca++ inﬂux is a major side effect of glutamate
excitotoxicity implicated in stroke, acute brain and spinal cord inju-
ries, and many neurodegenerative diseases such as Parkinson's,
Alzheimer's, ALS and multiple sclerosis. It damages cells by activating
numerous enzymes that destroy cellular structures, such as the cyto-
skeleton, membrane and DNA. High Ca++ can also facilitate the open-
ing of the mPTP, which makes the inner mitochondrial membrane
permeable to small molecules less than 1.5 kDa and consequently
breaks down the outer mitochondrial membrane by increased osmot-
ic pressure. Release of Cytochrome C into the cytosol actives apopto-
sis, and spread of reactive oxygen species and mitochondrial Ca++
further damages the cell. As a result, the mitochondrial membrane
potential is compromised, and the electron transport chain and ATP
production are disabled.
Ca++ arrests mitochondria via the EF-hands of Miro, which is crit-
ical for neurons to resist glutamate excitotoxicity [19], probably by
accumulating more mitochondria to buffer extra Ca++ and supply
more ATP as a means of cell survival. Although in many diseases glu-
tamate excitotoxicity or elevation of Ca++ is not the primary cause of
pathology, it may well be the primary factor that leads to cell death.
Will manipulation of mitochondrial motility in order to best allocate
mitochondria to subcellular regions with highest Ca++ inﬂux help
preserve the longevity of neurons under these stressful conditions?
Combined with other strategies to prevent the detrimental damages
caused by high Ca++, such as usage of mPTP inhibitors [104], this is
an exciting and innovative area to explore to better understand dis-
ease progression and improve treatment strategies.4.2. Other evidence
4.2.1. Alzheimer's disease
Alzheimer's disease is the most common neurodegenerative dis-
ease characterized by loss of neurons in cerebral cortex. Both the
“amyloid” hypothesis of amyloid β deposits and the “tau” hypothesis
of neuroﬁbrillary tangles exist to explain the causes of neuronal
death. Reduced mitochondrial motility has been observed in various
disease models of Alzheimer's [8–10,105–108], and the precise mech-
anisms remain unclear. Amyloid β peptides have been shown to in-
hibit mitochondrial transport in cultured neurons through PKA
(protein kinase A) and GSK3β pathways [9]. Hyperphosphorylation
or overexpression of Tau also inhibits mitochondrial movement,
probably by disrupting axonal cytoskeleton including both microtu-
bules and actin [10,108].
4.2.2. Huntington's disease
Huntington's disease is another neurodegenerative disease affect-
ing striatal and cortical neurons. It is caused by mutant expansions of
a polyglutamine region in the huntingtin (HTT) gene. Mutant, but not
wild type HTT decreases bi-directional mitochondrial motility in both
rodent neuronal cultures and transgenic animals [11,109]. Long mu-
tant HTT protein stretches could certainly jam microtubule tracks by
interacting with cytoskeletal components and transport motors
[109], but a speciﬁc binding between HTT and milton is also possible:
milton is a distant homologue of human HAP1 (huntingtin-associated
protein 1), which binds to HTT and dynactin [34].
4.2.3. ALS (Lou Gehrig's disease)
ALS (Lou Gehrig's disease) is caused by degeneration of upper and
lower motor neurons in the spinal cord and cortex. Bi-directional ax-
onal movement of mitochondria is decreased in various ALS disease
models [7,72,110,111]. Defects in kinesin or dynein function have
been suggested to cause mitochondrial arrest in certain Cu/Zn super-
oxide dismutase-1 (SOD1)‐related ALS models [7,110,111]. A recent
study proposed another interesting hypothesis: in ALS-associated
mutant VAPBP56S cells, intracellular Ca++ is elevated, which results
in halting mitochondrial transport via Miro [72].
4.2.4. CMT Type 2A
CMT Type 2A is a dominant inherited peripheral neurodegenera-
tive disease caused primarily by mutations in MFN2, which controls
mitochondrial outer membrane fusion. As discussed above, both
MFN1 and MFN2 are targets of Parkin and important for mitophagy
[98–103]. Interestingly, they also interact with mammalian Miro
and milton [112]. Disease-causing mutant MFN2 or knockdown of
MFN2 in neuronal cultures signiﬁcantly abolishes bi-directional mito-
chondrial motility [6,112], similarly to knockdown of Miro2 [112].
This poses an intriguing model in which MFN and the KHC/milton/
Miro complex may coordinate with each other to regulate mitochon-
drial motility, as well as mitochondrial fusion and mitophagy.
4.2.5. Schizophrenia
Schizophrenia is a mental illness characterized by a person's break-
down in perception and emotion. Little is known about themolecular, an-
atomical, and physiological mechanisms underlying its pathogenesis.
Recently, mitochondrial dysfunction and misdistribution have been
found related to the disorder [113]. Interestingly, when a schizophrenia-
susceptibility gene product DISC1 (disrupted in schizophrenia 1) is either
knocked down or overexpressed in rodent cultured neurons, mitochon-
drial motility is misregulated [13]. DISC1 is distributed to various subcel-
lular locations including mitochondria [114], and is involved in the
regulation of numerous cellular events such as neuronal development,
proliferation andmigration [115]. Could abnormalmitochondrialmotility
caused bymutant DISC1 or other proteins contribute to or exacerbate dis-
turbances of neuronal growth, function, and structures that might lead to
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mitochondrial movement in various psychiatric disease models is an ex-
cellent place to start testing this hypothesis.
5. Closing remarks
Regulation of neuronal mitochondrial motility is an emerging
frontier, and the more we understand the underlying mechanisms
the more we appreciate how signiﬁcant they are to neuronal function
and survival. The delicacy and complexity of these mechanisms re-
ﬂects heterogeneous and specialized needs for mitochondria on an
accurate temporal and spatial scale among subcellular regions of a
neuron. Mitochondrial dynamics allow neurons to respond precisely
to changes in their activity and environment. Local signals are crucial
to maintaining energy homeostasis and thereby to supporting neuro-
nal function. A better understanding of these mechanisms will help us
decipher the mystery of mitochondria, and shed light on the right
course of action to sustain the healthy life of a neuron, or reverse or
delay the progression of a dying neuron.
Acknowledgement
This work is supported by NIH ROO067066 (X.W.), and William
and Bernice E Bumpus Foundation Innovation Award (X.W.). We
thank Cindy Samos, Nicholas Risso, Drs. Gary Steinberg and Thomas
Schwarz for critical reading of the manuscript.
References
[1] T. Oh-hama, Evolutionary consideration on 5-aminolevulinate synthase in na-
ture, Orig. Life Evol. Biosph. 27 (1997) 405–412.
[2] M.F. Rossier, T channels and steroid biosynthesis: in search of a link with mito-
chondria, Cell Calcium 40 (2006) 155–164.
[3] H.M. McBride, M. Neuspiel, S. Wasiak, Mitochondria: more than just a power-
house, Curr. Biol. 16 (2006) R551–R560.
[4] R.H. Baloh, Mitochondrial dynamics and peripheral neuropathy, Neuroscientist
14 (2008) 12–18.
[5] B. Westerman, Mitochondrial fusion and ﬁssion in cell life and death, Nat. Rev.
Mol. Cell Biol. 11 (2010) 872–884.
[6] R.H. Baloh, R.E. Schmidt, A. Pestronk, J. Milbrandt, Altered axonal mitochondrial
transport in the pathogenesis of Charcot–Marie–Tooth disease from mitofusin 2
mutations, J. Neurosci. 27 (2007) 422–430.
[7] K.J. De Vos, A.L. Chapman, M.E. Tennant, C. Manser, E.L. Tudor, K.F. Lau, J.
Brownlees, S. Ackerley, P.J. Shaw, D.M. McLoughlin, C.E. Shaw, P.N. Leigh, C.J.
Miller, A.J. Grierson, Familial amyotrophic lateral sclerosis-linked SOD1 mutants
perturb fast axonal transport to reduce axonal mitochondrial content, Hum.
Mol. Genet. 16 (2007) 2720–2728.
[8] G. Pigino, G. Morﬁni, A. Pelsman, M.P. Mattson, S.T. Brady, J. Busciglio,
Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport, J.
Neurosci. 23 (2003) 4499–4508.
[9] Y. Rui, P. Tiwari, Z. Xie, J.Q. Zheng, Acute impairment of mitochondrial trafﬁcking
by beta-amyloid peptides in hippocampal neurons, J. Neurosci. 26 (2006)
10480–10487.
[10] E. Thies, E.M. Mandelkow, Missorting of tau in neurons causes degeneration of
synapses that can be rescued by the kinase MARK2/Par-1, J. Neurosci. 27
(2007) 2896–2907.
[11] E. Trushina, R.B. Dyer, J.D. Badger, D. Ure, L. Eide, D.D. Tran, B.T. Vrieze, V.
Legendre-Guillemin, P.S. McPherson, B.S. Mandavilli, B. Van Houten, S. Zeitlin,
M. McNiven, R. Aebersold, M. Hayden, J.E. Parisi, E. Seeberg, I. Dragatsis, K.
Doyle, A. Bender, C. Chacko, C.T. McMurray, Mutant huntingtin impairs axonal
trafﬁcking in mammalian neurons in vivo and in vitro, Mol. Cell. Biol. 24
(2004) 8195–8209.
[12] X. Wang, D. Winter, G. Ashraﬁ, J. Schlehe, Y.L. Wong, D. Selkoe, S. Rice, J. Steen,
M.J. LaVoie, T.L. Schwarz, PINK1 and parkin target miro for phosphorylation
and degradation to arrest mitochondrial motility, Cell 147 (2011) 893–906.
[13] T.A. Atkin, A.F. MacAskill, N.J. Brandon, J.T. Kittler, Disrupted in schizophrenia-1
regulates intracellular trafﬁcking of mitochondria in neurons, Mol. Psychiatry 16
(2011) 122–124.
[14] A. Letai, Growth factor withdrawal and apoptosis: the middle game, Mol. Cell 21
(2006) 728–730.
[15] Z. Sheng, Q. Cai, Mitochondrial transport in neurons: impact on synaptic homeo-
stasis and neurodegeneration, Nat. Rev. Neurosci. 13 (2012) 77–93.
[16] E.A. Schon, S. Przedborski, Mitochondria: the next (neurode)generation, Neuron
23 (2011) 1033–1053.
[17] S. Chen, G.C. Owens, K.L. Crossin, D.B. Edelman, Serotonin stimulates mitochon-
drial transport in hippocampal neurons, Mol. Cell. Neurosci. 36 (2007) 472–483.[18] C.C. Overly, H.I. Rieff, P.J. Hollenbeck, Organellemotility andmetabolism in axons vs
dendrites of cultured hippocampal neurons, J. Cell Sci. 109 (1996) 971–980.
[19] X. Wang, T.L. Schwarz, The mechanism of Ca2+‐dependent regulation of
kinesin-mediated mitochondrial motility, Cell 136 (2009) 163–174.
[20] J. Waters, S.J. Smith, Mitochondria and release at hippocampal synapses,
Pﬂugers Arch. 447 (2003) 363–370.
[21] P.J. Hollenbeck, W.M. Saxton, The axonal transport of mitochondria, J. Cell Sci.
118 (2005) 5411–5419.
[22] G. Twig, X. Liu, M. Liesa, J.D. Wikstrom, A.J. Molina, G. Las, G. Yaniv, G. Hajnóczky,
O.S. Shirihai, Biophysical properties of mitochondrial fusion events in pancreatic
beta-cells and cardiac cells unravel potential control mechanisms of its selectiv-
ity, Am. J. Physiol. Cell Physiol. 299 (2010) C477–C487.
[23] D.T. Chang, A.S. Honick, I.J. Reynolds, Mitochondrial trafﬁcking to synapses in
cultured primary cortical neurons, J. Neurosci. 26 (2006) 7035–7045.
[24] P.W. Baas, M.M. Black, G.A. Banker, Changes in microtubule polarity orientation
during the development of hippocampal neurons in culture, J. Cell Biol. 109
(1989) 3085–3094.
[25] D. Pathak, K.J. Sepp, P.J. Hollenbeck, Evidence that myosin activity opposes
microtubule-based axonal transport of mitochondria, J. Neurosci. 30 (2010)
8984–8992.
[26] H. Aizawa, Y. Sekine, R. Takemura, Z. Zhang, M. Nangaku, N. Hirokawa, Kinesin
family in murine central nervous system, J. Cell Biol. 119 (1992) 1287–1296.
[27] Y. Kanai, Y. Okada, Y. Tanaka, A. Harada, S. Terada, N. Hirokawa, KIF5C, a novel
neuronal kinesin enriched in motor neurons, J. Neurosci. 20 (2000) 6374–6384.
[28] N. Hirokawa, Y. Noda, Intracellular transport and kinesin superfamily, KIFs:
structure, function and dynamics, Physiol. Rev. 88 (2008) 1089–1118.
[29] Y. Tanaka, Y. Kanai, Y. Okada, S. Nonaka, S. Takeda, A. Harada, N. Hirokawa,
Targeted disruption of mouse conventional kinesin heavy chain results in ab-
normal perinuclear clustering of mitochondria, Cell 93 (1998) 1147–1158.
[30] A.D. Pilling, D. Horiuchi, C.M. Lively, W.M. Saxton, Kinesin-1 and dynein are the
primary motors for fast axonal transport of mitochondria in Drosophila motor
axons, Mol. Biol. Cell 17 (2006) 2057–2068.
[31] E.E. Glater, L.J. Megeath, R.S. Stowers, T.L. Schwarz, Axonal transport of mito-
chondria requires Milton to recruit kinesin heavy chain and is light chain inde-
pendent, J. Cell Biol. 173 (2006) 545–557.
[32] M. Nangaku, R.S. Yoshitake, Y. Okada, Y. Noda, R. Takemura, H. Yamazaki, N.
Hirokawa, KIF1B, a novel microtubule plus end-directed monomeric motor pro-
tein for transport of mitochondria, Cell 79 (1994) 1209–1220.
[33] K. Tanaka, Y. Sugiura, R. Ichishita, K. Mihara, T. Oka, KLP6: a newly identiﬁed
kinesin that regulates the morphology and transport of mitochondria in neuro-
nal cells, J. Cell Sci. 124 (2011) 2457–2465.
[34] R.S. Stowers, L.J. Megeath, J. Go'rska-Andrzejak, I.A. Meinertzhagen, T.L. Schwarz,
Axonal transport of mitochondria to synapses depends on Milton, a novel Dro-
sophila protein, Neuron 36 (2002) 1063–1077.
[35] K. Brickley, M.J. Smith, M. Beck, F.A. Stephenson, GIRF-1 and OIP106, members of a
novel gene family of coiled-coil domain proteins, J. Biol. Chem. 280 (2005)
14723–14732.
[36] M.J. Smith, K. Pozo, K. Brickley, F.A. Stephenson, Mapping the GIRF-1 binding do-
main of the kinesin, KIF5C, substantiates a role for GIRF-1 as an adaptor protein
in the anterograde trafﬁcking of cargoes, J. Biol. Chem. 281 (2006) 27216–27228.
[37] K. Brickley, F.A. Stephenson, Trafﬁcking kinesin protein (TRAK)-mediated trans-
port of mitochondria in axons of hippocampal neurons, J. Biol. Chem. 286 (2011)
18079–18092.
[38] A. Grishin, H. Li, E.S. Levitan, E. Zaks-Makhina, Identiﬁcation of
gamma-aminobutyric acid receptor interacting factor 1 (TRAK2) as a trafﬁcking
factor for the K+ channel Kir2.1, J. Biol. Chem. 281 (2006) 30104–30111.
[39] E. Kirk, L.S. Chin, L. Li, GRIF1 binds Hrs and is a new regulator of endosomal traf-
ﬁcking, J. Cell Sci. 119 (2006) 4689–4701.
[40] E. Webber, L. Li, L.S. Chin, Hypertonia-associated protein Trak1 is a novel regula-
tor of endosome-to-lysosome trafﬁcking, J. Mol. Biol. 382 (2008) 638–651.
[41] A. Fransson, A. Ruusala, P. Aspenstrom, Atypical rho GTPases have roles in mito-
chondrial homeostasis and apoptosis, J. Biol. Chem. 278 (2002) 6495–6502.
[42] A. Fransson, A. Ruusala, P. Aspenstrom, The atypical rho GTPases miro-1 and
miro-2 have essential roles in mitochondrial trafﬁcking, Biochem. Biophys.
Res. Commun. 344 (2006) 500–510.
[43] X. Guo, G.T. Macleod, A. Wellington, F. Hu, S. Panchumarthi, M. Schoenﬁeld, L.
Martin, M.P. Charlton, H.L. Atwood, K.E. Zinsmaier, The GTPase dMiro is required
for axonal transport of mitochondria to Drosophila synapses, Neuron 47 (2005)
379–393.
[44] Q. Cai, C. Gerwin, Z.H. Sheng, Syntabulin mediated anterograde transport of mi-
tochondria along neuronal processes, J. Cell Biol. 170 (2005) 959–969.
[45] J. Ikuta, A. Maturana, T. Fujita, T. Okajima, K. Tatematsu, K. Tanizawa, S. Kuroda,
Fasciculation and elongation protein zeta-1 (FEZ1) participates in the polariza-
tion of hippocampal neuron by controlling the mitochondrial motility, Biochem.
Biophys. Res. Commun. 353 (2006) 127–132.
[46] T. Fujita, A. Maturana, J. Ikuta, J. Hamada, S. Walchli, T. Suzuki, H. Sawa, M.W.
Wooten, T. Okajima, K. Tatematsu, K. Tanizawa, S. Kuroda, Axonal guidance pro-
tein FEZ1 associates with tubulin and kinesin motor protein to transport mito-
chondria in neurites of NGF-stimulated PC12 cells, Biochem. Biophys. Res.
Commun. 361 (2007) 605–610.
[47] K.I. Cho, Y. Cai, H. Yi, A. Yeh, A. Aslanukov, P.A. Ferreira, Association of the
kinesin-binding domain of RanBP2 to KIF5B and KIF5C determines mitochondria
localization and function, Trafﬁc 8 (2007) 1722–1735.
[48] M.J. Wozniak, M. Melzer, C. Dorner, H. Haring, R. Lammers, The novel protein
KBP regulates mitochondria localization by interaction with a kinesin-like pro-
tein, BMC Cell Biol. 6 (2005) 35.
193J.R. Lovas, X. Wang / Biochimica et Biophysica Acta 1833 (2013) 184–194[49] D.A. Lyons, S.G. Naylor, S. Mercurio, C. Dominguez, W.S. Talbot, KBP is essential
for axonal structure, outgrowth and maintenance in zebraﬁsh, providing insight
into the cellular basis of Goldberg–Shprintzen syndrome, Development 135
(2008) 599–608.
[50] S.J. King, T.A. Schroer, Dynactin increases the processivity of the cytoplasmic dy-
nein motor, Nat. Cell Biol. 2 (2000) 20–24.
[51] M. Haghnia, V. Cavalli, S.B. Shah, K. Schimmelpfeng, R. Brusch, G. Yang, C.
Herrera, A. Pilling, L.S.B. Goldstein, Dynactin is required for coordinated and bi-
directional motility, but not for dynein membrane attachment, Mol. Biol. Cell 18
(2007) 2081–2089.
[52] G.J. Russo, K. Louie, A. Wellington, G.T. Macleod, F. Hu, S. Panchumarthi, K.E.
Zinsmaier, Drosophila Miro is required for both anterograde and retrograde ax-
onal mitochondrial transport, J. Neurosci. 29 (2009) 5443–5455.
[53] R.L. Morris, P.J. Hollenbeck, Axonal transport of mitochondria along microtubules
and F-actin in living vertebrate neurons, J. Cell Biol. 131 (1995) 1315–1326.
[54] O.A. Quintero, M.M. DiVito, R.C. Adikes, M.B. Kortan, L.B. Case, A.J. Lier, N.S.
Panaretos, S.Q. Slater, M. Rengarajan, M. Feliu, R. Cheney, Human Myo19 is a
novel myosin that associates with mitochondria, Curr. Biol. 19 (2009)
2008–2013.
[55] J.S. Berg, B.C. Powell, R.E. Cheney, A millennial myosin census, Mol. Biol. Cell 12
(2001) 780–794.
[56] P.C. Bridgman, Myosin-dependent transport in neurons, J. Neurobiol. 58 (2004)
164–174.
[57] J.Y. Sung, O. Engmann, M.A. Teylan, A.C. Nairn, P. Greengard, Y. Kim,WAVE1 con-
trols neuronal activity induced mitochondrial distribution in dendritic spines,
Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 3112–3116.
[58] S.R. Chada, P.J. Hollenbeck, Nerve growth factor signaling regulates motility and
docking of axonal mitochondria, Curr. Biol. 14 (2004) 1272–1276.
[59] J.S. Kang, J.H. Tian, P.Y. Pan, P. Zald, C. Li, C. Deng, Z.H. Sheng, Docking of axonal
mitochondria by syntaphilin controls their mobility and affects short-term facil-
itation, Cell 132 (2008) 137–148.
[60] Y.M. Chen, C. Gerwin, Z.H. Sheng, Dynein light chain LC8 regulates
syntaphilin-mediated mitochondrial docking in axons, J. Neurosci. 29 (2009)
9429–9438.
[61] R.T. Cox, A.C. Spradling, Milton controls the early acquisition of mitochondria by
Drosophila oocytes, Development 133 (2006) 3371–3377.
[62] F.A. Stephenson, K. Brickley, Chapter 6: mechanisms of neuronal mitochondrial
transport, in: A. Wyttenbach, V. O'Connor (Eds.), Folding for the Synapse,
Springer, New York, 2011, pp. 105–119.
[63] S.P. Iyer, G.W. Hart, Roles of the tetratricopeptide repeat domain in O-GlcNAc
transferase targeting and protein substrate speciﬁcity, J. Biol. Chem. 278
(2003) 24608–24626.
[64] K. Brickley, K. Pozo, F.A. Stephenson, N-acetylglucosamine transferase is an inte-
gral component of a kinesin-directed mitochondrial trafﬁcking complex, Bio-
chim. Biophys. Acta 1813 (2011) 269–281.
[65] G.W. Hart, M.P. Housley, C. Slawson, Cycling of O-linked beta-N-acetylglucosamine
on nucleocytoplasmic proteins, Nature 446 (2007) 1017–1022.
[66] G. Manning, D.B. Whyte, R. Martinez, T. Hunter, S. Sudarsanam, The protein ki-
nase complement of the human genome, Science 298 (2002) 1912–1934.
[67] R. Shaﬁ, S.P.N. Iyer, L.G. Ellies, N. O'Donnell, K.W. Marek, D. Chui, G.W. Hart, J.D.
Marth, The O-GlcNAc transferase gene resides on the X chromosome and is es-
sential for embryonic stem cell viability and mouse ontogeny, Proc. Natl. Acad.
Sci. U.S.A. 97 (2000) 5735–5739.
[68] V.S. Van Laar, B. Arnold, S.J. Cassady, C.T. Chu, E.A. Burton, S.B. Berman, Bioener-
getics of neurons inhibit the translocation response of Parkin following rapid
mitochondrial depolarization, Hum. Mol. Genet. 20 (2011) 927–940.
[69] M. Saotome, D. Saﬁulina, G. Szabadkai, S. Das, A. Fransson, P. Aspenstrom, R.
Rizzuto, G. Hajnoczky, Bidirectional Ca++‐dependent control of mitochondrial
dynamics by the Miro GTPase, Proc. Natl. Acad. Sci. U.S.A. 105 (2008)
20728–20733.
[70] A.F. Macaskill, J.E. Rinholm, A.E. Twelvetrees, I.L. Arancibia-Carcamo, J. Muir, A.
Fransson, P. Aspenstrom, D. Attwell, J.T. Kittler, Miro1 is a calcium sensor for glu-
tamate receptor-dependent localization of mitochondria at synapses, Neuron 61
(2009) 541–555.
[71] Z. Yang, D.S. Steele, Effects of cytosolic ATP on spontaneous and triggered Ca++‐
induced Ca++ release in permeabilised rat ventricular myocytes, J. Physiol. 523
(2000) 29–44.
[72] G.M. Mórotz1, K.J. De Vos, A. Vagnoni, S. Ackerley, C.E. Shaw, C.C.J. Miller,
Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium
homeostasis to disrupt axonal transport of mitochondria, Hum. Mol. Genet. 21
(2012) 1979–1988.
[73] T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, S. Minoshima, M.
Yokochi, Y. Mizuno, N. Shimizu, Mutations in the parkin gene cause autosomal
recessive juvenile parkinsonism, Nature 392 (1998) 605–608.
[74] E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, S. Gispert,
Z. Ali, D. Del Turco, A.R. Bentivoglio, D.G. Healy, A. Albanese, R. Nussbaum, R.
Gonzalez-Maldonado, T. Deller, S. Salvi, P. Cortelli, W.P. Gilkes, D.S.
Latchman, R.J. Harvey, B. Dallapiccola, G. Auburger, N.W. Wood, Hereditary
early-onset Parkinson's disease caused by mutations in PINK1, Science 304
(2004) 1158–1160.
[75] S.M. Jin, M. Lazarou, C. Wang, L.A. Kane, D.P. Narendra, R.J. Youle, Mitochondrial
membrane potential regulates PINK1 import and proteolytic destabilization by
PARL, J. Cell Biol. 191 (2010) 933–942.
[76] I.E. Clark, M.W. Dodson, C. Jiang, J.H. Cao, J.R. Huh, J.H. Seol, S.J. Yoo, B.A. Hay, M.
Guo, Drosophila pink1 is required for mitochondrial function and interacts ge-
netically with parkin, Nature 441 (2006) 1162–1166.[77] N. Exner, B. Treske, D. Paquet, K. Holmstrom, C. Schiesling, S. Gispert, I.
Carballo-Carbajal, D. Berg, H.H. Hoepken, T. Gasser, R. Kruger, K.F. Winklhoffer,
F. Vogel, A.S. Reichert, G. Auburger, P.J. Kahle, B. Schmid, C. Haass,
Loss-of-function human PINK1 results in mitochondrial pathology and can be
rescued by parkin, J. Neurosci. 27 (2007) 12413–12418.
[78] J. Park, S.B. Lee, S. Lee, Y. Kim, S. Song, S. Kim, E. Bae, J. Kim, M. Shong, J.M. Kim, J.
Chung, Mitochondrial dysfunction in Drosophila PINK1 mutants is complemen-
ted by parkin, Nature 441 (2006) 1157–1161.
[79] A.C. Poole, R.E. Thomas, L.A. Andrews, H.M. McBride, A.J. Whitworth, L.J.
Pallanck, The PINK1/Parkin pathway regulates mitochondrial morphology,
Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 1638–1643.
[80] Y. Yang, S. Gehrke, Y. Imai, Z. Huang, Y. Ouyang, J.W. Wang, L. Yang, M.F. Beal, H.
Vogel, B. Lu, Mitochondrial pathology and muscle and dopaminergic neuron de-
generation caused by inactivation of Drosophila Pink1 is rescued by Parkin, Proc.
Natl. Acad. Sci. U.S.A. 103 (2006) 10793–10798.
[81] S. Geisler, K.M. Holmstrom, D. Skujat, F.C. Fiesel, O.C. Rothfuss, P.J. Kahle, W.
Springer, PINK1/Parkin mediated mitophagy is dependent on VDAC1 and
p62/SQSTM1, Nat. Cell Biol. 12 (2010) 119–131.
[82] D.P. Narendra, A. Tanaka, D.F. Suen, R.J. Youle, Parkin is recruited selectively to im-
pairedmitochondria andpromotes their autophagy, J. Cell Biol. 183 (2008) 795–803.
[83] D.P. Narendra, S.M. Jin, A. Tanaka, D.F. Suen, C.A. Gautier, J. Shen, M.R. Cookson,
R.J. Youle, PINK1 is selectively stabilized on impaired mitochondria to activate
parkin, PLoS Biol. 8 (2010) e1000298.
[84] A.J. Whitworth, L.J. Pallanck, The PINK1/Parkin pathway: a mitochondrial quality
control system? J. Bioenerg. Biomembr. 41 (2009) 499–503.
[85] R.J. Youle, D.P. Narendra, Mechanisms of mitophagy, Nat. Rev. Mol. Cell Biol. 12
(2011) 9–14.
[86] A. Weihofen, K.J. Thomas, B.L. Ostaszewski, M.R. Cookson, D.J. Selkoe, Pink1
forms a multi-protein complex with miro and Milton, linking pink1 function
to mitochondrial trafﬁcking, Biochemistry 48 (2009) 2045–2052.
[87] S. Liu, T. Sawada, S. Lee, W. Yu, G. Silverio, P. Alapatt, I. Millan, A. Shen, W.
Saxton, T. Kanao, R. Takahashi, H. Nobutaka, Y. Imai, B. Lu, Parkinson's disease‐
associated kinase PINK1 regulates Miro protein level and axonal transport of mi-
tochondria, PLoS Genet. 8 (2012) e1002537.
[88] M. Lazarou, S.M.L.A. Kane, R.J. Youle, Role of PINK1 binding to the TOM complex
and alternate intracellular membranes in recruitment and activation of the E3
ligase Parkin, Dev. Cell 22 (2012) 320–333.
[89] R.A. Nixon, A.M. Cataldo, P.A. Paskevich, D.J. Hamilton, T.R. Wheelock, L.
Kanaley-Andrews, The lysosomal system in neurons, involvement at multiple
stages of Alzheimer's disease pathogenesis, Ann. N. Y. Acad. Sci. 674 (1992) 65–88.
[90] K.P. Gatzinsky, C.H. Berthold, Lysosomal activity at nodes of Ranvier during ret-
rograde axonal transport of horseradish peroxidase in alpha-motor neurons of
the cat, J. Neurocytol. 19 (1990) 989–1002.
[91] Y. Li, S. Lim, D. Hoffman, P. Aspenstrom, H.J. Federoff, D.A. Rempe, HUMMR, a
hypoxia- and HIF-1alpha-inducible protein, alters mitochondrial distribution
and transport, J. Cell Biol. 185 (2009) 1065–1081.
[92] S.L. Mironov, ADP regulates movements of mitochondria in neurons, Biophys. J.
92 (2007) 2944–2952.
[93] S. Chen, G.C. Owens, D.B. Edelman, Dopamine inhibits mitochondrial motility in
hippocampal neurons, PLoS One 3 (2008) e2804.
[94] G. Morﬁni, G. Szebenyi, R. Elluru, N. Ratner, S.T. Brady, Glycogen synthase kinase
3 phosphorylates kinesin light chains and negatively regulates kinesin-based
motility, EMBO J. 21 (2002) 281–293.
[95] G. Pigino, G. Morﬁni, A. Pelsman, M.P. Mattson, S.T. Brady, J. Busciglio,
Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport, J.
Neurosci. 23 (2003) 4499–4508.
[96] S.R. Chada, P.J. Hollenbeck, Mitochondrial movement and positioning in axons:
the role of growth factor signaling, J. Exp. Biol. 206 (2003) 1985–1992.
[97] D.J. Surmeier, J.N. Guzman, J. Sanchez-Padilla, J.A. Goldberg, What causes death of
dopaminergic neurons in Parkinson's disease? Prog. Brain Res. 183 (2010) 59–77.
[98] A. Tanaka, M.M. Cleland, S. Xu, D.P. Narendra, D. Suen, M. Karbowski, R.J. Youle,
Proteasome and p97 mediate mitophagy and degradation of mitofusins induced
by Parkin, J. Cell Biol. 27 (2010) 1367–1380.
[99] M.E. Gegg, J.M. Cooper, K.Y. Chau, M. Rojo, A.H.V. Schapira, J. Taanman, Mitofusin
1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon
induction of mitophagy, Hum. Mol. Genet. 19 (2010) 4861–4870.
[100] N.C. Chan, A.M. Salazar, A.H. Pham, M.J. Sweredoski, N.J. Kolawa, R.L. Graham, S.
Hess, D.C. Chan, Broad activation of the ubiquitin–proteasome system by Parkin
is critical for mitophagy, Hum. Mol. Genet. 20 (2011) 1726–1737.
[101] A.C. Poole, R.E. Thomas, S. Yu, E.S. Vincow, L.J. Pallanck, The mitochondrial
fusion-promoting factor mitofusin is a substrate of the PINK1/parkin pathway,
PLoS One 5 (2010) e10054.
[102] M. Karbowski, R.J. Youle, Regulating mitochondrial outer membrane proteins by
ubiquitination and proteasomal degradation, Curr. Opin. Cell Biol. 23 (2011)
476–482.
[103] E. Ziviani, R.N. Tao, A.J. Whitworth, Drosophila parkin requires PINK1 for mito-
chondrial translocation and ubiquitinates mitofusin, Proc. Natl. Acad. Sci. U.S.A.
107 (2010) 5018–5023.
[104] M. Forte, B.G. Gold, G. Marracci, P. Chaudhary, E. Basso, D. Johnsen, X. Yu, J.
Fowlkes, M. Rahder, K. Stem, P. Bernardi, D. Bourdette, Cyclophilin D inactiva-
tion protects axons in experimental autoimmune encephalomyelitis, an ani-
mal model of multiple sclerosis, Proc. Natl. Acad. Sci. U.S.A. 104 (2007)
7558–7563.
[105] P.H. Reddy, R. Tripathi, Q. Troung, K. Tirumala, T.P. Reddy, V. Anekonda, U.P.
Shirendeb, M.J. Calkins, A.P. Reddy, P. Mao, M. Manczak, Abnormal mitochondri-
al dynamics and synaptic degeneration as early events in Alzheimer's disease:
194 J.R. Lovas, X. Wang / Biochimica et Biophysica Acta 1833 (2013) 184–194implications to mitochondria-targeted antioxidant therapeutics, Biochim.
Biophys. Acta 1822 (2012) 639–649.
[106] M.J. Calkins, M. Manczak, P. Mao, U. Shirendeb, P.H. Reddy, Impaired mitochon-
drial biogenesis, defective axonal transport of mitochondria, abnormal mito-
chondrial dynamics and synaptic degeneration in a mouse model of
Alzheimer's disease, Hum. Mol. Genet. 20 (2011) 4515–4529.
[107] P.H. Reddy, Abnormal tau, mitochondrial dysfunction, impaired axonal trans-
port of mitochondria, and synaptic deprivation in Alzheimer's disease, Brain
Res. 30 (2011) 136–148.
[108] K. Shahpasand, I. Uemura, T. Saito, T. Asano, K. Hata, K. Shibata, Y.
Toyoshima, M. Hasegawa, S. Hisanaga, Regulation of mitochondrial trans-
port and inter-microtubule spacing by tau phosphorylation at the sites
hyperphosphorylated in Alzheimer's disease, J. Neurosci. 32 (2012)
2430–2441.
[109] D.T. Chang, G.L. Rintoul, S. Pandipati, I.J. Reynolds, Mutant huntingtin aggregates
impair mitochondrial movement and trafﬁcking in cortical neurons, Neurobiol.
Dis. 22 (2006) 388–400.[110] L.G. Bilsland, E. Sahai, G. Kelly, M. Golding, L. Greensmith, G. Schiavo, Deﬁcits in
axonal transport precede ALS symptoms in vivo, Proc. Natl. Acad. Sci. U.S.A. 107
(2010) 20523–20528.
[111] P. Shi, A.L. Ström, J. Gal, H. Zhu, Effects of ALS-related SOD1 mutants on dynein-
and KIF5-mediated retrograde and anterograde axonal transport, Biochim.
Biophys. Acta 1802 (2010) 707–716.
[112] A. Misko, S. Jiang, I. Wegorzewska, J. Milbrandt, R.H. Baloh, Mitofusin 2 is neces-
sary for transport of axonal mitochondria and interacts with the Miro/Milton
complex, J. Neurosci. 30 (2010) 4232–4240.
[113] D. Ben-Shachar, D. Laifenfeld, Mitochondria, synaptic plasticity, and schizophre-
nia, Int. Rev. Neurobiol. 59 (2004) 273–296.
[114] R. James, R.R. Adams, S. Christie, S.R. Buchanan, D.J. Porteous, J.K. Millar,
Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein
that predominantly localizes to mitochondria, Mol. Cell. Neurosci. 26 (2004)
112–122.
[115] N.J. Bradshaw, D.J. Porteous, DISC1-binding proteins in neuronal development,
signaling and schizophrenia, Neuropharmacology 62 (2012) 1230–1241.
